Cornell Translational Behavioral Science Research Consortium: Hypertension Qualitative Study
2 other identifiers
observational
60
1 country
1
Brief Summary
To explore the meaning, causes and treatment of hypertension in eligible patients. In addition the cultural, social, and psychological factors that either facilitate or serve, as barriers to behavioral change will be illuminated in this patient population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2003
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2003
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2003
CompletedFirst Submitted
Initial submission to the registry
September 23, 2005
CompletedFirst Posted
Study publicly available on registry
September 27, 2005
CompletedApril 3, 2008
March 1, 2008
September 23, 2005
March 31, 2008
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- Patients must be self-identified as African-Americans.
- All patients must be aged 18 years and older.
- All patients must be diagnosed as having hypertension: For this project, hypertension will be defined according to the widely accepted criteria of the 6th Joint National Committee (JNC VI) Guidelines on Prevention, Detection, Evaluation and Treatment of Hypertension, which is a systolic blood pressure \> 140 mm hg or a diastolic blood pressure \> 90 mm hg or if participants are taking any prescribed antihypertensive medication.
- Patients must be able to provide informed consent in English.
You may not qualify if:
- Patients who refuse to participate
- Patients who are unable to provide informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The New York Presbyterian Hospital-Weill Medical Center
New York, New York, 10021, United States
Related Publications (2)
Factors That Influence Medication Adherence Among African-Americans With Hypertension. Moore, JA, Boutin-Foster, C, Charlson, ME. Weill Medical College of Cornell University, New York, NY. Presented at the 12th Annual NHLBI Cardiovascular Minority Research Supplement Awardee Session, American Heart Association, November 2004.
BACKGROUNDOgedegbe GO, Boutin-Foster C, Wells MT, Allegrante JP, Isen AM, Jobe JB, Charlson ME. A randomized controlled trial of positive-affect intervention and medication adherence in hypertensive African Americans. Arch Intern Med. 2012 Feb 27;172(4):322-6. doi: 10.1001/archinternmed.2011.1307. Epub 2012 Jan 23.
PMID: 22269592DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Carla Boutin-Foster, MD, MS
Weill Medical College of Cornell University
- PRINCIPAL INVESTIGATOR
Gbenga Ogedegbe, MD, MS
Columbia University
- STUDY DIRECTOR
Mary E Charlson, MD
Weill Medical College of Cornell University
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 23, 2005
First Posted
September 27, 2005
Study Start
April 1, 2003
Study Completion
September 1, 2003
Last Updated
April 3, 2008
Record last verified: 2008-03